TAIHO ONCOLOGY
Prescription Drugs

TAIHO ONCOLOGY: Risk & public record

TAIHO ONCOLOGY: 143 research papers in five years.

Data updated Nov 21, 2026 · Back to the company report

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Public record

TAIHO ONCOLOGY: 143 research papers in five years.

Research outputpapers its people wrote, per OpenAlex
143papers in five years
8.3kcitations
Colorectal Cancer Treatments and Studies
Medicine
122 papers
Colorectal Cancer Surgical Treatments
Medicine
47 papers
Acute Myeloid Leukemia Research
Medicine
43 papers
Fibroblast Growth Factor Research
Biochemistry, Genetics and Molecular Biology
42 papers
Lung Cancer Treatments and Mutations
Medicine
40 papers

Works most with: The University of Texas MD Anderson Cancer Center, Institut Gustave Roussy, Yale University, Yale New Haven Health System, Smilow Cancer Hospital, CERCA Institution

Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.